EUVIMEDObjevte EUVIMED
Multizentrische StudieOpen access · CC BY-NC-ND 4.0

Circulating Cell‐Free DNA Concentration as a Biomarker in Head and Neck Cancer

Ana María Rodríguez-Ces iD, Óscar Rapado-González iD, Santiago Aguín-Losada, Inés Formoso-García, José Luís López-Cedrún iD, Gabriel Triana-Martínez, Rafael López-López iD, María Mercedes Suárez-Cunqueiro iD

Oral Diseases · 2025

DOI: 10.1111/odi.70002 ↗

At a glance

Multizentrische Studie in Oral Diseases, 2025. Written by Ana María Rodríguez-Ces and 7 co-authors. Institution: Department of Surgery and Medical-Surgical Specialties, Medicine and Dentistry School, Universidade de Santiago de Compostela (USC), Santiago de Comp…. Major MEDLINE topics: Cell-Free Nucleic Acids, Biomarkers, Tumor, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck. Cited 4 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Instituto de Salud Carlos III.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

Head and neck squamous cell carcinoma (HNSCC), particularly human papillomavirus (HPV) ‐negative HNSCC, poses a significant clinical challenge due to late diagnoses and poor survival. This study evaluates the potential of circulating cell‐free DNA (ccfDNA) as a minimally invasive biomarker for diagnosis, prognosis and disease monitoring in HNSCC.

Methods

We conducted a multicentre, prospective study enrolling 85 patients across all disease stages and 28 healthy controls, using two quantification ccfDNA methods: fluorometry (Qubit) and quantitative real‐time polymerase chain reaction (qPCR).

Results

Baseline plasma ccfDNA concentrations were significantly elevated in HNSCC patients compared to healthy controls, with an area under the curve of 0.705. Higher ccfDNA levels were observed in early‐stage HNSCC patients. While ccfDNA levels correlated with age, no significant associations were found with tumour stage or location. Patients with lower post‐treatment ccfDNA levels demonstrated longer median progression‐free survival (PFS) (16.37 months vs. 9.63 months, p < 0.05). Longitudinal analysis of locally advanced HNSCC revealed significant inter‐patient variability in ccfDNA kinetics.

Conclusions

Our study demonstrates the potential value of fluorometric ccfDNA quantification as a diagnostic, prognostic and monitoring biomarker for HNSCC. However, further well‐designed studies must be carried out to enhance the clinical utility of ccfDNA as a biomarker for HNSCC management.

Subjects

MeSH terms (MEDLINE)

Cell-Free Nucleic AcidsBiomarkers, TumorHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckHumansMaleFemaleMiddle AgedProspective StudiesAgedAdultPrognosisCase-Control StudiesFluorometryReal-Time Polymerase Chain Reaction

Author keywords

biomarkercell‐free DNAdiagnostichead and neck cancerquantification

Substances

Cell-Free Nucleic AcidsBiomarkers, Tumor

Authors and institutions

  • Department of Surgery and Medical-Surgical Specialties, Medicine and Dentistry School, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.
  • Galician Precision Oncology Research Group (ONCOGAL), Medicine and Dentistry School, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.
  • Liquid Biopsy Analysis Unit, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela Foundation (FIDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Co…
  • Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
  • Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center Raquel Seruca (Por…
  • Medical Devices Research Group, International Iberian Nanotechnology Laboratory (INL), Braga, Portugal.

ORCID profiles: Ana María Rodríguez-Ces, Óscar Rapado-González, José Luís López-Cedrún, Rafael López-López, María Mercedes Suárez-Cunqueiro

Funding

  • Instituto de Salud Carlos III

Cite

APA

Rodríguez-Ces, A. M., Rapado-González, Ó., Aguín-Losada, S., Formoso-García, I., López-Cedrún, J. L., Triana-Martínez, G., López-López, R., & Suárez-Cunqueiro, M. M. (2025). Circulating Cell‐Free DNA Concentration as a Biomarker in Head and Neck Cancer. Oral Diseases. https://doi.org/10.1111/odi.70002

Vancouver

Rodríguez-Ces AM, Rapado-González Ó, Aguín-Losada S, Formoso-García I, López-Cedrún JL, Triana-Martínez G, et al. Circulating Cell‐Free DNA Concentration as a Biomarker in Head and Neck Cancer. Oral Diseases. 2025. doi:10.1111/odi.70002

BibTeX
@article{RodrguezCes2025,
  author = {Rodríguez-Ces, Ana María and Rapado-González, Óscar and Aguín-Losada, Santiago and Formoso-García, Inés and López-Cedrún, José Luís and Triana-Martínez, Gabriel and López-López, Rafael and Suárez-Cunqueiro, María Mercedes},
  title = {Circulating Cell‐Free DNA Concentration as a Biomarker in Head and Neck Cancer},
  journal = {Oral Diseases},
  year = {2025},
  doi = {10.1111/odi.70002}
}
Start for free →